已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

The Evolution of Commercial Antibody Formulations

化学 抗体 生物 免疫学
作者
Carl Mieczkowski
出处
期刊:Journal of Pharmaceutical Sciences [Elsevier BV]
卷期号:112 (7): 1801-1810 被引量:13
标识
DOI:10.1016/j.xphs.2023.03.026
摘要

It has been nearly four decades since the first therapeutic monoclonal antibodies were approved and made available for widespread human use. Herein, US and EU approved antibody formulations are reviewed, and their nature and compositions are evaluated over time. From 1986 through Jan 2023, significant formulation trends have occurred and to represent this, 165 commercial antibody therapeutic formulations were binned into 5 different periods of time. Overall, we have observed the following: 1) The average formulation pH has decreased in recent years by over 0.5 units along with a decrease in variability that is largely driven by non-high concentration liquid in vial presentations for IV administration, 2) The use of certain excipients and buffers such as histidine, sucrose, metal chelators, arginine and methionine has become significantly more common, whereas formulations that contain phosphate, salt, no sugar or no surfactant have fallen out of favor, 3) Overall formulation space has increasingly become more homogenous and has converged in terms of formulation pH and excipient preferences regardless of formulation concentration, drug product presentation, and route of administration, 4) The average calculated isoelectric point (pI) has decreased 0.26 units, and 5) Overall, the average formulation pH and calculated pI for all commercial antibodies surveyed was 6.0 and 8.4, respectively. These trends and formulation convergence may be driven by multiple factors such as advancements in high-throughput computational and analytical technologies, the increased emphasis and understanding of certain developability attributes and formulation principles during lead selection and formulation development, and the adoption of low-risk development platform approaches.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
棣棣完成签到,获得积分10
刚刚
Lee完成签到,获得积分10
1秒前
清爽笑翠完成签到 ,获得积分10
1秒前
沐风完成签到,获得积分20
3秒前
7秒前
英姑应助合适的台灯采纳,获得10
10秒前
11秒前
吾系渣渣辉完成签到 ,获得积分10
12秒前
瞬间完成签到 ,获得积分10
12秒前
CodeCraft应助CHEN采纳,获得10
13秒前
么大人发布了新的文献求助10
14秒前
桃李春风一杯酒完成签到,获得积分10
14秒前
路易十三完成签到 ,获得积分10
15秒前
17秒前
19秒前
GingerF完成签到,获得积分0
20秒前
21秒前
苏灿应助哈哈哈哈采纳,获得10
22秒前
24秒前
Foxjker完成签到 ,获得积分10
28秒前
YDX完成签到,获得积分20
29秒前
31秒前
CartGo完成签到,获得积分10
34秒前
脑洞疼应助十二采纳,获得10
34秒前
kenti2023完成签到 ,获得积分10
35秒前
Meyako完成签到 ,获得积分10
35秒前
CHEN发布了新的文献求助10
37秒前
amber完成签到 ,获得积分10
37秒前
自信的网络完成签到 ,获得积分10
39秒前
马马完成签到 ,获得积分10
40秒前
Aurora发布了新的文献求助10
42秒前
万能图书馆应助纯真衬衫采纳,获得10
43秒前
马马完成签到 ,获得积分10
46秒前
48秒前
MCRing完成签到,获得积分10
48秒前
小L完成签到 ,获得积分10
49秒前
环走鱼尾纹完成签到 ,获得积分10
49秒前
文子完成签到 ,获得积分10
50秒前
量子星尘发布了新的文献求助10
52秒前
派大星发布了新的文献求助10
52秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976583
求助须知:如何正确求助?哪些是违规求助? 3520659
关于积分的说明 11204399
捐赠科研通 3257298
什么是DOI,文献DOI怎么找? 1798683
邀请新用户注册赠送积分活动 877842
科研通“疑难数据库(出版商)”最低求助积分说明 806595